Gabriel India Ltd files response to SEBI clarification on Q4 FY2025‑26 results

What Gabriel India Ltd announced

Gabriel India Limited filed a Reply to Clarification – Financial results with the National Stock Exchange (NSE) on 9 July 2026. The filing addresses the exchange’s request for clarification under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, relating to the company’s financial results for the quarter ended 31 March 2026.

The company’s response, enclosed in the filing, satisfies the NSE’s requirement for additional information. No amendment to the previously disclosed numbers was indicated in the reply.

Details of the regulatory query

The NSE sought clarification on the quarterly financial statements submitted by Gabriel India Ltd for the period ending 31 Mar 2026. Under Regulation 33, listed entities must provide accurate and complete financial disclosures. The exchange’s notice asked the company to explain any perceived discrepancies or to furnish missing data.

Gabriel India’s reply, filed at 09:52 UTC on 9 July 2026, confirms that the quarterly results were prepared in accordance with applicable accounting standards and that no material misstatement exists. The company did not disclose any changes to revenue, profit, or other key metrics in this response.

Key facts at a glance

Why this matters for investors

The filing demonstrates Gabriel India Ltd’s compliance with SEBI’s disclosure framework. By providing the requested clarification, the company avoids potential regulatory penalties and reassures investors that its quarterly reporting adheres to statutory standards. Since the response does not indicate any revision of the financial figures, shareholders can consider the originally published results as still valid.

Conclusion

Gabriel India Limited has fulfilled the NSE’s request for clarification on its Q4 FY2025‑26 results, filing its response on 9 July 2026. The company affirmed the accuracy of its previously disclosed numbers and did not disclose any amendments. No further regulatory steps were mentioned in the filing.